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Abstract
Background: The development of active surveillance programmes for transmissible spongiform
encephalopathies of small ruminants across Europe has led to the recent identification of a
previously undetected form of ovine prion disease, 'atypical' scrapie. Knowledge of the
epidemiology of this disease is still limited, as is whether it represents a risk for animal and/or public
health.
The detection of atypical scrapie has been related to the use of only some of the EU agreed rapid
tests. Information about the rapid tests used is not, as yet, available from public reports on the
surveillance of transmissible spongiform encephalopathies in small ruminants. We collected
detailed results of active surveillance from European countries to estimate and to compare the
prevalence of atypical scrapie and classical scrapie in sheep for each country stratified by each
surveillance stream; healthy slaughtered and found dead adult sheep.
Results: From the 20 participating countries, it appeared that atypical scrapie was detected in
Europe wherever the conditions necessary for its diagnosis were present. In most countries,
atypical scrapie and classical scrapie occurred at low prevalence level. The classical scrapie
prevalence estimates were more variable than those for atypical scrapie, which appeared
remarkably homogeneous across countries, surveillance streams and calendar years of surveillance.
Differences were observed in the age and genotype of atypical scrapie and classical scrapie cases
that are consistent with previous published findings.
Conclusion: This work suggests that atypical scrapie is not rare compared to classical scrapie. The
homogeneity of its prevalence, whatever the country, stream of surveillance or year of detection,
contrasts with the epidemiological pattern of classical scrapie. This suggests that the aetiology of
atypical scrapie differs from that of classical scrapie.
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Background
Classical scrapie (CS) is a transmissible, chronic, neuro-
logical disease affecting small ruminants that was first
described clinically in the 18th century [1]. It belongs to
the group of diseases called transmissible spongiform
encephalopathies (TSEs) together with, among others,
bovine spongiform encephalopathy (BSE) in cattle and
Creutzfeldt-Jakob disease (CJD) in humans. CS has a
worldwide distribution with the exception of Australia
and New Zealand, which are usually recognized as free of
CS [2].
BSE was first detected in 1986 [3] and the BSE-agent is the
probable cause of variant Creutzfeldt-Jakob disease
(vCJD) in humans [4,5]. Sheep in Europe have most prob-
ably been exposed to feed concentrates contaminated
with the BSE-agent [6], and it cannot be ruled out that
sheep might have been infected with BSE in natural con-
ditions. In experimental conditions, BSE-infection can
transmit horizontally between sheep [7], if such transmis-
sion occurred in usual husbandry conditions, it is feared
that BSE-infection might persist in the sheep population
with potential consequences for public health [8-10].
Because of this, the European Union (EU) introduced an
active surveillance programme for TSE in sheep from
2002. The surveillance programme targeted sheep older
than 18 months, both those sheep routinely slaughtered
in abattoirs (healthy slaughter) and those sheep either
found-dead or killed but not intended for human con-
sumption (fallen stock). A sample size was set for each tar-
get population in each country [11,12]. Later, the sample
size requirements varied with amendments to regulation
EC 999/2001 in 2002 [13], 2003 [14], and 2006 [15]. EU
member states could test above these minimum require-
ments and non-EU member states were free to establish
their own objectives.
Scrapie Nor98 was first detected in sheep in Norway in
1998 [16]. After the introduction of the active surveillance
programmes in EU, scrapie Nor98 and TSEs in sheep des-
ignated "atypical scrapie" or "Nor98-like" have been
reported from several other European countries [17-23].
Atypical scrapie (AS) cases have been characterized by the
distribution of pathological changes and deposits of the
disease-associated isoform of the prion protein (PrPSc),
which have been most prominent in the cerebellum. The
PrPSc has not been detected in peripheral tissues. The PrPSc
associated with AS cases has a characteristic Western Blot
profile [16,17] and animals with specific prion protein
(PrP) genotypes usually with the AHQ or AF141RQ allele
are associated with the occurrence of the disease [16,24-
27]. In 2005, the European Food Safety Agency (EFSA)
produced three documents, hereby used as reference. The
first provided harmonised criteria to discriminate
between AS (including scrapie Nor98) and CS [28]. The
other two documents evaluated submitted tests. They rec-
ommended the use of eight tests (Bio-Rad TeSeE (test A)
and Bio-Rad TeSeE Sheep/Goat (test G), IDEXX Herd-
Check BSE-Scrapie Antigen Test Kit (test F), Enfer TSE Test
v.2.0 (test C), InPro CDI-5, Institut Pourquier Scrapie
Test, Prionics Check LIA Small Ruminants (test D), Prion-
ics Check WB Small Ruminants (test B)) for the detection
of CS on brainstem samples. For the detection of AS, all
tests above, except test D, could be used on cerebellum or
cerebrum samples but only three rapid tests (tests A, F and
G) were recommended for the detection of AS in brain-
stem samples [29,30].
In a Norwegian case-control study, based on 28 cases and
102 controls, none of the risk factors that measure trans-
mission of scrapie between flocks by movement of ani-
mals or animal-to-animal contact were significantly
associated with the occurrence of scrapie Nor98. In Great
Britain, a study found that the flocks associated with atyp-
ical scrapie had a higher size and dealt with more stock
than control farms but no connection between atypical
scrapie farms was found [31]. Different authors have
observed that one or two additional case of AS have been
found in only a few flocks in which all or most of the adult
sheep in flock were examined for TSEs when culled due to
the detection of an AS [16,20,26,32]. Although AS was
reported in 2005 to be transmissible into mice transgenic
for ovine PrP [33]and into sheep [34] in 2007, the epide-
miological evidences cited above suggest either that AS is
not transmissible by direct contact between sheep, or that
the transmission rate under natural conditions is low. Due
to this and because the distribution of PrPSc has been lim-
ited to the CNS, a spontaneous aetiology for AS has been
suggested [16].
In 2005 data on AS were collected from 13 countries in a
questionnaire-based study [35]. The results of this study
showed firstly that 95% of AS cases were detected by the
Bio-Rad Platelia/TeSeE rapid test (which represented 42%
of the total number of tests) and secondly that the preva-
lence of AS was more similar between countries than the
prevalence of CS was. It was suggested that the differences
in the prevalence of AS might partly be explained by dif-
ferences in sampling with regard to the surveillance
streams and differences in the age structure or PrP geno-
type distribution of the population. However, these
hypotheses could not be tested due to lack of data.
The aim of this work has been to estimate and to compare
the prevalence of AS and CS in sheep for each country
stratified by surveillance stream for the period 2002–
2006.BMC Veterinary Research 2008, 4:19 http://www.biomedcentral.com/1746-6148/4/19
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Results
Participation
Twenty-three replies were returned from 22 countries and
the Basque country of Spain. Three replies were excluded
from the analysis because of missing information. Data
from the following 20 countries or region within a coun-
try (hereafter called country) were included in the analy-
sis: (Basque Country (Spain), Belgium, Cyprus, Czech
Republic, Denmark, Estonia, Finland, France, Great Brit-
ain, Iceland, Ireland, Italy, Lithuania, Northern Ireland,
Norway, Portugal, Slovenia, Sweden, Switzerland, The
Netherlands).
Bias in the surveillance programmes
Most countries (14/20) considered that animals tested
within the healthy slaughter programme were representa-
tive of the slaughtered population, the other six consid-
ered that some biases could have occurred.
Diagnostic tests used
The number of test results available and the type of diag-
nostic test used in active surveillance varied between
countries. A total of 1,764,056 tests results were reported.
Fifteen different diagnostic tests or combinations of tests
were represented. Test A was the most common. This was
used in 15 countries and represented 50% of the total
number of analyses. The second most commonly used
was test B, which was used in eight countries and repre-
sented 23% of the total number of analyses (Table 1).
The large-scale active surveillance programmes started in
2002; although some countries started earlier in healthy
slaughter (Ireland, Iceland, Lithuania, Norway) or in
fallen stock (Estonia, Iceland, Lithuania, Switzerland)
populations, it was decided to limit the analysis to surveil-
lance data from 2002 and onwards.
From 2002 to 2006, 56% of the samples in healthy
slaughter and 42% of the samples in fallen stock were
examined using test A. The overall use of tests recom-
mended for the detection of AS in active surveillance var-
ied between countries (Figure 1) and with time. In 2002,
ten countries (Belgium, Estonia, Finland, France, Great
Britain, Italy, Lithuania, Norway, Portugal, Sweden) used
test A; by 2005 it was used by 15 countries (as above plus
Basque Country, Cyprus, Iceland, Northern Ireland, Swit-
zerland). The proportion of samples examined by test A
has also increased in countries that used several tests. In
2006, tests A, F and G were used for examination of 73%
and 53% of the samples in healthy slaughter and fallen
stock, respectively.
Case detection
Fourteen countries reported AS cases. It was the only TSE
in sheep reported in four countries (Figure 2). Five coun-
tries detected CS cases only. Most (94%) of the AS cases
and 43% of the CS cases were detected by test A (Figure 3).
Table 1: Tests used in sheep TSE active surveillance between 2001 and 2006. 
Test code Test or combination of tests reported Share of total reported 
tests (%)
Countries in which the specified diagnostic test 
was used
Countries Number of countries
A Bio-Rad Platelia test and Bio-Rad TeSeE 50 BC, BE, CY, EE, FI, FR, GB, 
IS, IT, LT, NI, NL, NO, PT, 
SE
15
B Prionics Check Western test 23 CZ, DK, FI, FR, GB, IT, NL, 
SL
8
C Enfer-test 9 BC, DK, FR, IE, IT, LT, NI 7
D Prionics-Check LIA test 5 BC, CY, CZ, FR, IT 5
E Enfer TSE Kit version 2.0 5 CZ, FR, IE, LT, SL 5
F IDEXX HerdCheck BSE-Scrapie Antigen 
Test Kit, EIA
3D K ,  F R 2
G Bio-Rad TeSeE Sheep/Goat test 2 CH, IS, NO 3
H Prionics-Check Western Small Ruminant 
test
1 CH, CZ, NL 3
I Other (Histopathology and/or 
Immunohistochemistry; Prionics-Check 
Western Blot modified; Prionics Check 
Western test & Prionics-Check LIA test in 
parallel; Prionics-Check Western Small 
Ruminant and Bio-Rad TeSeE Sheep/
Goat test in line; Enfer test and Bio-Rad 
TeSeE in parallel; Prionics Check PrioSTRIP; 
Prionics-Check Lia Small Ruminant)
10 CH, CY, CZ, FR, IS, IE, LT, 
NI, NL, NO
12
Tests associated with the detection of AS case(s) are in bold, tests recommended by EFSA are underlined.BMC Veterinary Research 2008, 4:19 http://www.biomedcentral.com/1746-6148/4/19
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Classical scrapie prevalence estimates
The annual national CSPE for each surveillance stream,
for which the number of tests exceeds 500, is presented in
Figure 4 to Figure 7 (for prevalence estimates for years
with less than 500 tests [see Additional file 1]). Due to
higher values of the CSPE in Slovenia and due to lack of
separation of AS and CS cases in data from Cyprus the esti-
mates from these countries are reported in separate figures
(Figure 6 and 7).
For each year and country in which at least one CS case
was detected, and more than 500 animals were tested, the
CSPE in healthy slaughtered animals varied from 0.03‰
[0.0; 0.2] in Switzerland in 2004 to 2.8‰ [0.3;10.1] in
Northern Ireland in 2005 (150.9‰ [105.6;206.3] in
Cyprus in 2004 for TSE positive). The CSPE in fallen stock
varied from 0.2‰ [0.0;1.2] in Norway in 2006 to 22‰
[15.3;29.5] in Slovenia in 2005 (245.6‰ [169.8;335.1]
in Cyprus in 2003 for TSE positive). CSPE was null in 48
country-years and 6 countries did not detect any CS case.
Atypical scrapie prevalence estimates
Fourteen countries reported AS cases and it was the only
TSE in sheep reported in four countries. The annual
national prevalence estimates of AS (ASPE) for each sur-
veillance programme are presented in Figure 8 and Figure
9.
For each year and country in which at least one AS case
was detected and more than 500 animals tested, the ASPE
in healthy slaughtered animals varied from 0.1‰
[0.0;0.3] in Switzerland in 2004 to 1.4‰ [0.8;2.3] in
Great Britain in 2005 and the ASPE in fallen stock varied
from 0.3‰ [0.0;1.5] in Norway in 2005 to 2.5‰
Quantity of samples examined by tests A, F and G Figure 1
Quantity of samples examined by tests A, F and G. In red, five countries processed more than 50,000 tests. In orange, 
one country processed between 20,000 to 50,000 tests. In yellow, four countries processed 5,000 to 20,000 tests. In pale yel-
low, five countries, performed less than 5,000 tests. In blue, four countries did not perform any of these tests. In grey, 11 coun-
tries did not answer the questionnaire (including Malta).BMC Veterinary Research 2008, 4:19 http://www.biomedcentral.com/1746-6148/4/19
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[1.0;5.2] in Great Britain in 2003. ASPE was null in 15
country-years and 5 countries did not detect any AS case.
Variability of classical scrapie prevalence estimates
The CS prevalence was significantly higher in fallen stock
than in healthy slaughter in seven countries according to
logistic regression models (Table 2). Six countries had
detected CS but without significant difference in the CSPE
between streams. Out of these, CS cases had been detected
in three (Basque country, Norway, Switzerland) only
occasionally. The prevalence in fallen stock was higher
than in healthy slaughter in Belgium, although not signif-
icantly so (p-value = 0.06) and the prevalence in fallen
stock was lower than in healthy slaughter in two countries
(Czech Republic, p-value = 0.07 and Northern Ireland p-
value = 0.35).
The detection of CS cases also varied with time. In seven
countries (Basque country, Belgium, Czech Republic, Ice-
land, Northern Ireland, Norway, Slovenia), CS cases were
not detected in every year, in Switzerland one case was
found during the single year of surveillance. There was
time-dependent variability of the CS prevalence in five
countries, including Cyprus for TSE positives in the
healthy slaughter population only, and Ireland in the
fallen stock only. The trend was a decrease with time in all
countries except Italy and Great-Britain. The results of the
Chi-square linear trend test were consistent with the
results of the logistic regression model, except for Italy
where the trend was significant in healthy slaughter (χ2 =
6.39, df = 1, p-value = 0.01) but not in fallen stock (χ2 =
1.42, df = 1, p-value = 0.23).
Cases detected in sheep in active surveillance Figure 2
Cases detected in sheep in active surveillance. In red, four countries detected AS only. In strip red and yellow, ten coun-
tries detected AS and CS. In yellow, three countries detected CS only. In yellow with black spots, one country detected TSE 
unclassified case. In green, two countries didn't detect any case. In grey, 11 countries did not answer the questionnaire (includ-
ing Malta). The period covered ranges from 2002 to 2006. AS cases may have been detected by other means than through 
active surveillance.BMC Veterinary Research 2008, 4:19 http://www.biomedcentral.com/1746-6148/4/19
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Variability of atypical scrapie prevalence estimates
No significant difference between the streams was found
in ten countries that detected atypical scrapie (all p-values
> 0.1 and OR close to 1). In four countries, the AS preva-
lence was significantly higher in fallen stock than in
healthy slaughter (Table 2).
In seven countries (Basque country, Belgium, Finland, Ice-
land, Northern Ireland, the Netherlands, Sweden) AS
cases were not detected in every year. No time-dependent
variability of the AS prevalence was found using logistic
regression with adjustment on surveillance stream and
time, parameterised as a categorical variable. However,
there were some discrepant results depending on the
parameterisation of the variable time. Significant time
dependant effects were found when time was set as a con-
tinuous variable or using the Chi-square test for linear
trend: significant decreases were found in France in
healthy slaughter (χ2 = 4.45, df = 1, p-value = 0.03), in
Great Britain in fallen stock (χ2 = 6.84, df = 1, p-value =
0.008), in Norway in fallen stock (χ2 = 3.90, df = 1, p-
value = 0.05) and an increase in Portugal in healthy
slaughter (χ2 = 11.13, df = 1, p-value = 0.0008).
Comparison of atypical scrapie and classical scrapie 
prevalence estimates
Differences between the ASPE and the CSPE were found in
six countries (Table 3). In France and Great Britain, the
ASPE was less than the CSPE in fallen stock. For the other
countries with a significant difference, the ASPEs were
greater than the CSPEs. The countries where no significant
difference was found had relatively less samples tested
than the other countries. The ORs could be calculated in
both surveillance streams for four countries. In these
countries, the ORs in the healthy slaughter stream were
higher than the ORs in fallen stock. In particular, the
probability (as a ratio) of detecting an AS case (rather than
a CS one) was three to six times higher among healthy
slaughter animals compared to fallen stock.
Probability to detect at least one case of AS
If one expects a country ASPE to be similar to the average
European ASPE, this prevalence could be estimated by the
ratio of the total number of AS cases detected by test A, F
or G over the total number of tests A, F or G, which was
0.65‰ for the 20 respondent countries.
The sensitivity of the surveillance programme can be sim-
ulated to range from 50% to 100%.
A numerical example (Table 4) shows that given the
number of samples examined with tests A, F and G in
Estonia (4092) and in Lithuania (1933) the probability
that no case is detected (given the assumed "design prev-
alence" of 0.65), even with a perfect sensitivity of the sur-
veillance programme (Se = 100%) is higher than 5%
(respectively 7% and 30%).
Comparison of the age of the cases
Data on the age of 1370 cases detected in healthy slaugh-
ter, fallen stock and TSE eradication programmes were
provided by 15 countries. AS cases were reported in all
classes of age over 18 months (Figure 10) and they were
older than CS cases in healthy slaughter (p-value < 1.10-5)
and in fallen stock (p-value < 1.10-5). Also, there was no
significant difference between the age of AS cases in
healthy slaughter and fallen stock (p-value = 0.14)
although CS cases were older in healthy slaughter than in
fallen stock (p-value = 0.001).
Description of the genotype of the cases
Eighteen countries provided the PrP genotype of 1258
cases detected in healthy slaughter and fallen stock (Figure
11).
The distribution of the allele frequencies (Table 5)
between AS and CS cases was different in healthy slaugh-
ter (χ2 = 300.6, df = 4, p-value < 10-5) and fallen stock (χ2
= 384.4, df = 4, p-value < 10-5). In both streams, the fre-
quency of ARR and AHQ carrier was higher in AS cases
than in CS cases and the frequency of VRQ carriers was
lower in AS cases than in CS cases. The allele frequency in
the two surveillance streams was similar for AS (χ2 =
2.547, df = 4, p-value = 0.63). In contrast the allele fre-
quencies differed for CS (χ2 = 45.6, df = 4, p-value < 3.10-
9) with more ARR carriers and less ARQ carriers in healthy
slaughter compared to fallen stock.
Reported AS cases by test Figure 3
Reported AS cases by test. Percentage (number in brack-
ets) of AS cases detected in sheep through active surveillance 
in 20 EU countries between 2002 and 2006 per test or com-
bination of tests.BMC Veterinary Research 2008, 4:19 http://www.biomedcentral.com/1746-6148/4/19
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Sheep CSPE (‰) in healthy slaughter surveillance Figure 4
Sheep CSPE (‰) in healthy slaughter surveillance. Crude prevalence estimates are represented with their 95% confi-
dence intervals. The dashed line represents the mean CSPE in healthy slaughter for all the countries and all the years. Graph is 
restricted to country-years with more than 500 tests because confidence intervals were too large to fit on the graph with an 
appropriate scale. For 2006, some countries could not provide data for the full year. In Switzerland, surveillance was conducted 
from July 2004 to June 2005 and was referred to as a single year (2004).
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Sheep CSPE (‰) in fallen stock surveillance Figure 5
Sheep CSPE (‰) in fallen stock surveillance. Crude prevalence estimates are represented with their 95% confidence 
intervals. The dashed line represents the mean CSPE in fallen stock for all the countries and all the years. Graph is restricted to 
country-years with more than 500 tests because confidence intervals were too large to fit on the graph with an appropriate 
scale and not showing Slovenia due to higher prevalence. For 2006, some countries could not provide data for the full year. In 
Switzerland, surveillance was conducted from July 2004 to June 2005 and was referred to as a single year (2004).
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Sheep CSPE (‰) in fallen stock surveillance in Slovenia Figure 6
Sheep CSPE (‰) in fallen stock surveillance in Slovenia. Crude prevalence estimates are presented with their 95% 
confidence intervals.
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Sheep TSEs prevalence (‰) in active surveillance in Cyprus Figure 7
Sheep TSEs prevalence (‰) in active surveillance in Cyprus. Crude prevalence estimates are presented with their 95% 
confidence intervals.
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Sheep ASPE (‰) in healthy slaughter surveillance Figure 8
Sheep ASPE (‰) in healthy slaughter surveillance. Crude prevalence estimates are represented with their 95% confi-
dence intervals. The dashed line represents the mean ASPE in healthy slaughter for all the countries and all the years included 
in ASPE calculation. Graph is restricted to country-years with more than 500 tests A or G because confidence intervals were 
too large to fit on the graph with an appropriate scale. For 2006, some countries could not provide data for the full year. In 
Switzerland, surveillance was conducted from July 2004 to June 2005 and was referred to as a single year (2004).
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Sheep ASPE (‰), in fallen stock surveillance Figure 9
Sheep ASPE (‰), in fallen stock surveillance. Crude prevalence estimates are represented with their 95% confidence 
intervals. The dashed line represents the mean ASPE in fallen stock for all the countries and all the years included in ASPE cal-
culation. Graph is restricted to country-years with more than 500 tests A or G because confidence intervals were too large to 
fit on the graph with an appropriate scale.) For 2006, some countries could not provide data for the full year. In Switzerland, 
surveillance was conducted from July 2004 to June 2005 and was referred to as a single year (2004).
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Discussion
This study of the active surveillance for ovine TSEs in 20
European countries has produced estimates of the
detected prevalence of both CS and AS over the time
period 2002 to 2006, with respect to the surveillance
stream. This extends previous studies on scrapie preva-
lence in Europe which have either been limited to one
Table 2: Variability of AS and CS detection with surveillance stream (reference is healthy slaughter) and year of surveillance. 
Type of TSE Country Factor p OR CI95%
Atypical Finland (Fisher test) Surveillance stream 0.0321
Norway Surveillance stream < 1.10-5 4.27 [2.33, 7.83]
Portugal Surveillance stream 0.0088 1.64 [1.13, 2.37]
Switzerland Surveillance stream 0.0142 9.38 [1.57, 56.15]
Classical France Surveillance stream < 1.10-5 8.01 [6.15, 10.44]
Year of surveillance (linear) < 1.10-5 0.61 [0.58, 0.64]
Great Britain Surveillance stream < 1.10-5 5.04 [3.61, 7.03]
Year of surveillance (2003 vs 2002) 0.0022 0.53 [0.36, 0.80]
Year of surveillance (2004 vs 2002) 0.0325 0.54 [0.31, 0.95]
Year of surveillance (2005 vs 2002) 0.0488 0.61 [0.37, 1.00]
Year of surveillance (2006 vs 2002) < 1.10-5 0.25 [0.15, 0.39]
Iceland Surveillance stream < 1.10-5 304.40 [50.44, 1 836.84]
Ireland Surveillance stream < 1.10-5 29.19 [17.05, 49.97]
Year of surveillance (linear) 0.8895 0.99 [0.80, 1.21]
Interaction between surveillance stream and year of surveillance 
(linear)
0.0337 0.78 [0.61, 0.98]
Italy Surveillance stream < 1.10-5 5.68 [4.00, 8.05]
Year of surveillance (2003 vs 2002) 0.0013 0.44 [0.26, 0.72]
Year of surveillance (2004 vs 2002) 0.0001 0.26 [0.13, 0.50]
Year of surveillance (2005 vs 2002) 0.0002 0.35 [0.20, 0.61]
Year of surveillance (2006 vs 2002) 0.0006 0.45 [0.29, 0.71]
Slovenia (Fisher test) Surveillance stream 0.0037
The Netherlands Surveillance stream 0.0017 1.53 [1.17, 1.99]
TSE positive Cyprus Surveillance stream 0.2022 0.27 [0.04, 2.00]
Year of surveillance (2004 vs 2003) 0.0719 0.15 [0.02, 1.18]
Year of surveillance (2005 vs 2003) 0.0052 0.05 [0.01, 0.42]
Year of surveillance (2006 vs 2003) 0.0123 0.07 [0.01, 0.57]
Interaction between surveillance stream and year of surveillance 
(2004 vs 2003)
0.0635 7.13 [0.90, 56.75]
Interaction between surveillance stream and year of surveillance 
(2005 vs 2003)
0.0027 24.70 [3.05, 200.18]
Non-statistically significant results were not displayed.
Table 3: Comparison of detection of AS and CS in active surveillance in fallen stock and in healthy slaughter. OR is defined as chances 
to detect AS versus chances to detect CS. 
Country Surveillance stream Chi-square df p-value OR CI95%
France Healthy slaughter 68.63 1 < 1.10-5 3.96 [2.80,5.62]
Fallen stock 7.83 1 0.005 0.69 [0.54,0.89]
Great Britain Healthy slaughter 9.30 1 0.002 1.55 [1.17,2.05]
Fallen stock 22.03 1 < 1.10-5 0.37 [0.24,0.57]
Italy Fallen stock 21.60 1 < 1.10-5 0.16 [0.07,0.38]
Norway Healthy slaughter 19.17 1 1.10-5 45.00 [2.73,741.78,]
Fallen stock 14.71 1 0.0001 13.66 [2.60,71.71]
Portugal Healthy slaughter 107.38 1 < 1.10-5 367.66 [10.22,13 231.94]
Fallen stock 35.44 1 < 1.10-5 127.67 [3.51,4 637.69]
Sweden Fallen stock 5.56 1 0.02 21.00 [0.88,500.93]
Non-statistically significant results were not displayed.BMC Veterinary Research 2008, 4:19 http://www.biomedcentral.com/1746-6148/4/19
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region or country [36-39] or have not discriminated
between CS and AS [40,41].
The capacity to determine the presence of either type of
scrapie infection will depend on the true prevalence of
disease and on several aspects of the surveillance pro-
gramme. These are firstly, the ability to detect scrapie
infection (if it is present) with the use of an appropriate
screening test; secondly, the ability to confirm that diag-
nosis with relevant confirmatory tests; thirdly, the number
of samples tested, and fourthly, the design of the surveil-
lance programme. The latter includes many components
from the structure of the sampled population to the sam-
pling methodology used.
The detection of atypical scrapie – appropriate tests
The finding that the detection of AS was associated with
the use of test A is consistent with the previous results pre-
sented by Nöremark et al. [35] and case reports from
France [18], Germany [18], Great Britain [21], Ireland
[20], Norway (as Nor98) [16], Portugal [22], Spain [23]
and Sweden [17]. The tests recommended in the EFSA
evaluation account for an increasing proportion of the
total screening tests used (data not shown). It probably
explains why AS cases have now been detected in the
Basque country (Spain), Denmark, Finland, Iceland, Italy,
and the Netherlands, in addition to the eight European
countries where the disease has been previously reported
[17-22]. Neither Ireland nor Slovenia had used screening
tests recommended for the detection of AS and AS was not
reported via active surveillance in these countries. Two AS
cases have, however, been reported from Ireland through
the surveillance of clinical cases [20], which demonstrates
that AS is present within the Irish sheep population. We
observed that in two countries, test H and a modified ver-
sion of test B have detected two AS cases each out of
18,940 and 13,529 tests respectively. However according
to the trials organised by the EFSA [29], these tests could
have a lower sensitivity, and by the end of 2006 they were
still used on a limited scale compared to tests A, F or G
which may explain why they were less frequently associ-
ated with the detection of AS case.
Probability to detect at least one case of AS
Estonia and Lithuania have regularly used test A but have
not reported any case of AS. However, in these countries
the total number of samples tested with screening tests
recommended for the detection of AS is still relatively low.
If AS is present at the estimated European average AS prev-
alence, Estonia has more than a five per cent chance of not
yet detecting AS, whilst for Lithuania this chance exceeds
25 per cent. Therefore, AS is not necessarily absent from
these populations, but might have remained undetected
by chance because sufficient numbers of appropriate tests
have not yet accrued.
The confirmation of atypical scrapie
Most countries reported that their diagnostic capacity to
confirm AS was established in 2004. Some countries then
retrospectively confirmed inconclusive diagnostic screen-
ing test results from previous years. These cases have been
included when calculating the AS prevalence estimates. If
not all samples with inconclusive results were retested, it
could lead to an underestimation of the prevalence of AS.
Cyprus, is experiencing an epidemic of CS [42]. Discrimi-
natory tests performed on 838 Cypriot TSE cases detected
through TSE eradication programmes have not found any
AS (P. Stylianou, personal communication). Although
these samples are from outbreaks and are biased towards
CS, we consider it probable that the majority of TSE-cases
in Cyprus are CS. Therefore, we find it justified to compare
the prevalence estimates on TSE cases in Cyprus with the
prevalence estimates of CS from other countries. Never-
theless, the presence of AS cases cannot be ruled out.
The prevalence of scrapie (atypical and classical)
At less than nine per thousand animals tested in either
surveillance stream from the majority of countries, both
types of scrapie can be considered as rare diseases. The
exceptions are Slovenia, which has a slightly higher prev-
alence (< 30‰) of CS in the fallen stock stream, and
Cyprus for TSEs. The latter is a small, enclosed population
with high connectivity that is in the throes of a (compara-
tively) recent scrapie epidemic [42].
In four countries (Portugal, Denmark, Sweden and Fin-
land) AS cases were detected through the active surveil-
lance programme, in the absence of any case of CS in
sheep. The upper limit of the confidence intervals of the
prevalence estimates of the CS in these countries suggest
that if the disease exists it occurs at a very low level, yet one
cannot conclude freedom of the disease. The single case of
CS found in 2006 in Norway after five years of active sur-
veillance and 95,000 samples tested illustrates that CS
could remain undetected by the current surveillance pro-
grammes for a long time, as during the same period four
cases of CS were found through passive surveillance. This
is probably due to a low overall sensitivity of the surveil-
lance programmes. A lack of sensitivity of test A to detect
CS cases in VRQ allele carriers such as suggested by [43]
Table 4: Probability to detect zero case of AS depending on the 
sensitivity of the test (in column) and the number of tests (in 
row) for Estonia and Lithuania.
0.5 0.7 0.8 0.9 1
1933 (Estonia) 0.53 0.41 0.36 0.32 0.30
4092 (Lithuania) 0.26 0.15 0.12 0.09 0.07BMC Veterinary Research 2008, 4:19 http://www.biomedcentral.com/1746-6148/4/19
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could be part of the explanation. However, in countries
using different tests in parallel, the CSPE did not vary with
the nature of the test used (data not shown).
Under-estimation of prevalence estimates
Active surveillance for the estimation of the apparent
prevalence of infection of scrapie will always be an under-
estimate of the true prevalence of infection. This is due to
the long incubation period and the current absence of a
detectable early marker for infection. Furthermore, even if
the sheep tested within the healthy slaughter population
are thought to be representative of the slaughtered popu-
lation, this does not equate to the standing population.
For example, in Great Britain the healthy slaughter popu-
lation has been used to estimate the prevalence in the
national flock [37,44]. Differences in the age structure of
Age distribution of AS and CS cases according to stream of surveillance (in %) Figure 10
Age distribution of AS and CS cases according to stream of surveillance (in %).
[18−36[ [36−60[ [60−96[ >=96
Classical scrapie cases − Healthy slaughter
%
 
o
f
 
c
a
s
e
s
114 cases
33 37 40 4 4
0
1
0
2
0
3
0
4
0
5
0
[18−36[ [36−60[ [60−96[ >=96
Classical scrapie cases − Fallen stock
%
 
o
f
 
c
a
s
e
s
412 cases
165 157 79 11 4
0
1
0
2
0
3
0
4
0
5
0
[18−36[ [36−60[ [60−96[ >=96
Atypical scrapie cases − Healthy slaughter
%
 
o
f
 
c
a
s
e
s
178 cases
34 24 71 49
0
1
0
2
0
3
0
4
0
5
0
[18−36[ [36−60[ [60−96[ >=96
Atypical scrapie cases − Fallen stock
%
 
o
f
 
c
a
s
e
s
151 cases
22 18 60 51
0
1
0
2
0
3
0
4
0
5
0BMC Veterinary Research 2008, 4:19 http://www.biomedcentral.com/1746-6148/4/19
Page 15 of 24
(page number not for citation purposes)
source and sampled population could be a source of bias
that could not be ascertained in the absence of reliable
data.
The evaluation of EU agreed diagnostic tests [30,29] did
not include quantification of their sensitivity, which may
differ from test to test. The overall sensitivity will be
dependent on the stage of the disease and some infected
sheep will remain undetected [45,46]. The same may be
true for the screening test used on CSPE [43].
The estimation of the prevalence of AS is further compli-
cated by the different tissue distribution of PrPSc com-
pared to CS. The EFSA evaluation of small ruminant TSEs
tests estimated the capacity to detect Nor98 cases in cere-
brum samples [29,30]. The obex is the tissue that is usu-
ally analysed in active surveillance programmes, as it is
Genotype distribution of AS and CS cases Figure 11
Genotype distribution of AS and CS cases. Figure for 414 AS cases and 844 CS cases detected through active surveillance 
in fallen stock or healthy slaughter.
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the site used for the discriminatory testing of TSEs in
sheep to exclude BSE. The presence of PrPSc in the obex is
not a consistent finding in AS, whilst the cerebellum is a
site of increased deposition. Existence of cerebellum frag-
ments in brainstem samples might explain the positive
results for some cases [16-22,47,32]. Although the inclu-
sion of a sample from the cerebellum has been recom-
mended since January 2005 [48] it is not mandatory to
test it. The inclusion of cerebellum fragments in the sam-
ples analysed will thus increase the likelihood of the
detection of AS in that sample. If systematic differences in
application of this existed between laboratories, the prev-
alence estimates of AS might be biased.
Comparison of the prevalence of a scrapie-type between 
surveillance streams within a country
Higher prevalence estimates of scrapie in the fallen stock
stream when compared with the healthy slaughter stream
have been reported previously [49]. This may be due to
increased mortality amongst scrapie-infected sheep asso-
ciated with their scrapie-status i.e. scrapie-infected sheep
are less likely to survive to be submitted for healthy
slaughter. However, in [49], AS cases were not distin-
guished from CS cases. In our study this situation was
observed for CS in eight countries, and in Cyprus for all
TSE positive cases. In the six other countries, no difference
between streams was observed, which might be due to a
lack of power to detect a difference, if it exists, due to the
small sample sizes.
Prevalence estimates of AS were higher in the fallen stock
stream than in the healthy slaughter stream in four coun-
tries (Finland, Norway, Portugal and Switzerland). This
was not the case, however, in four other countries (France,
Great Britain, Iceland and Italy) where there was a differ-
ence observed for the prevalence of CS. Whether this
reflects a true difference, or absence of difference, is diffi-
cult to ascertain. Depending on countries, it may reflect
selection biases in the submission and collection of fallen
stock schemes, and/or different farming and slaughter
practices. Alternatively, it could be explained by differ-
ences in the age structure between the surveillance streams
within a country. No difference was, however, observed in
the age structure in countries where it could be tested
(Czech Republic, France and Norway). For both types of
scrapie, small sample sizes may have also explained the
absence of observed difference between streams. The
ratios found, of AS to CS for the prevalence estimates in
each of the surveillance streams, could represent an actual
difference in France, Great Britain and Italy, where large
number of animals have been tested and cases of either
disease are regularly found. If an actual difference does
exist, one possible explanation could be a higher age at
onset of clinical AS i.e. sheep become sick closer to the
end of their commercial lifespan.
Variation in the scrapie-type specific estimates within a 
surveillance stream over time
In our study, decreases in the prevalence estimates for CS
over time were observed in four countries and for the
ovine TSEs prevalence estimate in Cyprus. This could
result from a variety of factors. These include the effect of
genetic selection based on PrP genotype and the reduction
of sources of infection (control of animal movement,
eradication programme, control exposure to contami-
nated feed). Such reduction echoes results of studies that
evaluated control strategies based on mathematical mod-
els [42,50-52].
In most countries, time was not a significant factor for
ASPE. In France and Great Britain the observed trends in
ASPE could be spurious due to increased number of tests
in 2006, the discrepant outcomes between the Cochran
Hermitage test and the logistic regression are more likely
to occur with unbalanced counts [53]. The tests that found
significant effect in time assume a linear variation of the
prevalence which is not obvious. In addition, when the
time variable is parameterised as categorical, the estimates
of the coefficients of each year should be ordered in case
of monotonic variation; this was not the case. The changes
in the surveillance programme design in 2006 could have
resulted in selection bias, for instance, since the number
of tests increased in the second half of the year, the age
distribution of animals tested in 2006 could be different
compared to other years. In Norway, the decreased preva-
lence in fallen stock could be due to selection biases (such
as a decrease in reporting when farmers realized that older
animals were at higher risk for AS) and/or changes in the
age structure of the sampled population. In Portugal unre-
ported changes may have occurred in slaughterhouse
operations; all slaughtered sheep were supposed to be
sampled, yet the number of tests increased from 42,753 in
2004 to 53,748 in 2006. This would represent a 25 per
cent increase in the slaughter throughput, over the two
years period. In these four countries trend would need to
be confirmed by future observations.
Table 5: Number and frequency (%) of allele carriers among 1258 
AS and CS cases detected between 2002 and 2006 in healthy 
slaughter and fallen stock in 18 EU countries.
Allele Healthy slaughter Fallen stock
AS CS AS CS
ARR 132 (32.3) 48 (9.5) 65 (28.4) 19 (2.3)
ARQ 170 (41.6) 220 (43.7) 98 (42.8) 456 (56.3)
VRQ 3 (0.7) 196 (39.0) 2 (0.9) 285 (35.2)
ARH 5 (1.2) 24 (4.8) 6 (2.6) 38 (4.7)
AHQ 99 (24.2) 15 (3.0) 58 (25.3) 12 (1.5)BMC Veterinary Research 2008, 4:19 http://www.biomedcentral.com/1746-6148/4/19
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Genetic variability
It has previously been reported that the role of PrP genet-
ics differs in AS compared to CS. In the latter the risk of
developing clinical scrapie is greater for those sheep with
the VRQ/VRQ, ARH/VRQ, ARQ/VRQ and ARQ/ARQ gen-
otypes when compared with those that carry the AHQ and
ARR alleles [54,55]. There is little work published on the
relative risks of infection [56,57], although genotype-spe-
cific prevalence estimates by screening test have been pub-
lished for the early British active healthy slaughter stream
[43]. What makes AS so remarkable is the involvement of
alleles usually associated with low to negligible risks of
clinical scrapie [25-27,58]. The case data in the current
study are consistent with these previously reported find-
ings, it also exhibits the rarity of cases in animals carrying
the VRQ allele.
The impact of the genetic structure of the tested sheep
populations could not be assessed here. Although results
from surveys on genotype from healthy population were
provided and/or published [58-64], information on the
codon 141 is required when considering the risk of AS.
Age
Clinical scrapie is generally thought to occur most fre-
quently in two to five year old sheep [65]. Analysis of sur-
veillance data gave a mean age at death between 40 and 50
months of age [66] for clinical cases in the USA, and a
peak incidence in three to four year old animals in Great
Britain [41]. The high numbers of CS cases in the 18–36
months and 36–60 months categories, (and low numbers
in the over 60 months categories) for those culled in erad-
ication programmes and fallen stock, observed in our
study are consistent with these published findings. The
different profile for the age of CS cases in the healthy
slaughter population most probably reflects a different
underlying age distribution. I.e. an older population from
which CS cases have already been lost, either as clinical
cases, fallen stock, or culling activities. In contrast, in our
study, there is no 18–36 months old peak for AS cases;
only an increase in numbers with age in the healthy
slaughter and fallen stock populations. This is similar to
findings reported from a German study [26]. Whether the
difference between the age distributions of CS and AS is a
function of survival, genotype, incubation period or age
susceptibility remains to be established.
Bias in the surveillance programmes
The main potential for bias was the over-representation of
certain flocks and possible geographical biases due to
sampling rates applied in the different regions [39]. In
addition, diagnostic laboratories in different regions in
some countries used different tests, including those not
recommended to detect AS. In some countries, there was
the potential for seasonal bias either because of a change
in the use of the tests during the year or, for 2006, because
data did not cover the full year. For example, seasonal dif-
ferences in the numbers submitted could bias the preva-
lence estimates if there were differences in the age
distribution, or the breed of animals submitted that was
related to the annual pattern of production, and if age or
breed was associated with the outcome – a positive test
result. However it is difficult to ascertain how such biases
would influence the results without a dedicated study for
each country.
In many countries, collection of fallen stock was voluntary
or had been only recently organised on a compulsory
basis. It was, therefore, expected that an important, but
unknown, number of sheep that died on farms were not
submitted for sampling. Difficulties to organise a proper
TSE surveillance in small ruminants and especially in
fallen stock was already stressed by the Scientific steering
committee in charge of this matter [67]. The inclusion of
animals that originated from known infected farms was
reported in France (2002) [39] and in Ireland (2003 to
2006). In France, the decreasing trend observed in fallen
stock for the CSPE is still significant for the period 2003 to
2006. In Norway, where there was no rendering plant,
dead animals were reported to veterinary officers and TSE
suspects animals were preferentially sampled. This could
contribute to the explanation of the higher chance to
detect AS in fallen stock.
Demographic differences
In both surveillance streams, demographic differences in
the ovine population, especially those based on age and
PrP genotype could influence prevalence estimates. No
reliable data are currently available to standardise these
figures, which is why no between countries comparison
was performed. If such demographic data were collected
then it might be possible to compare active surveillance
data between countries. These limitations in the data also
apply to data collected during TSE eradication pro-
grammes; age and PrP genotype denominator data are
vital. Here, seven countries reported that they had
detected more than one case in the same farm, but we
have no further information on the monitoring activities
or the characteristics of these farms.
Comparison of the prevalence of atypical and classical 
scrapie within countries
Comparison of estimates of the prevalence of AS and CS
is a complex issue. Firstly, the potential biases in the struc-
ture and implementation of the surveillance programmes,
including the challenges of the diagnosis of AS can affect
the result. Secondly, each country has its own scrapie his-
tory with respect to its presence, introduction, establish-
ment and control activities. Thirdly, some differencesBMC Veterinary Research 2008, 4:19 http://www.biomedcentral.com/1746-6148/4/19
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might not have been detected because of only a limited
number of tests or of cases.
In two countries – Portugal and Sweden – where scrapie
was not reported for decades or was never reported, there
was an increased chance to detect AS, compared to CS. So
it could be considered that if CS were present, notwith-
standing selection biases in the surveillance programme,
it existed at an extremely low level. In contrast, in three
countries where CS exists and there have been a large
number of tests – France, Great Britain and Italy – there
was higher chance to detect CS in the time period studied,
compared to AS in fallen stock. It was also the case in the
Netherlands when comparison was done upon tests B
modified and H. In both France and Great Britain, how-
ever, there was increased chance to detect AS in the
healthy slaughter stream.
For France, Great Britain and Italy, the method used to test
the differences between the scrapie-type prevalence esti-
mates was not ideal since it assumes an absence of inter-
action between disease and time. This was not the case as
the trend in time was found to be statistically significant,
but did not have a strong slope. Hence, the methodology
might not be sufficiently robust for these conditions.
The ORs of the two types of scrapie by stream provides a
way to measure if the two streams of surveillance within a
country have similar outcomes and if some general pat-
tern could be observed across countries such as France,
Great-Britain, Norway and Portugal. However, the values
of these ORs depend on more than one factor and similar
results could come from different patterns. First, it
depends on the contrast between AS and CS in each
stream, the later being more frequent in fallen stock, sec-
ondly it is supported by the fact that CS is more frequent
in fallen stock than in healthy slaughter. Eventually, it
could indicate an higher probability of detecting AS
instead of CS in the healthy slaughter stream compared
with fallen stock. This could be due to some confounding
effects. The different age distribution within the two
streams, for instance, may account for that since AS
mostly affects the eldest animals. A lower diagnostic sen-
sitivity for AS in fallen stock could also contribute to that
result, however such artefact has so far never been
described from diagnostic reports on AS.
From our study, it would appear that AS is present wher-
ever the capacity to diagnose it exists and a sufficient
number of samples have been appropriately tested. In
some countries that have no or an extremely low preva-
lence of CS infection, AS exists at a low, constant and
homogenous prevalence between streams and countries.
In other countries that have a more substantial prevalence
of CS, (even if it is potentially decreasing), AS occurs,
again at a relatively homogeneous prevalence. The homo-
geneity of the prevalence of AS in populations in which
there are such variations in the prevalence of CS in popu-
lations would suggest that the aetiology and/or epidemi-
ology of the two scrapie-types differ. The homogeneity of
the prevalence estimates for AS provides support for the
argument that it is not an infectious process; this would
require the same conditions of transmission to exist in the
different countries and for them to be different from the
conditions of transmission of CS. Yet, these data do not
exclude an infectious process in which the transmission of
AS occurs at a low level especially since low prevalence
rates hinder observation of differences. In addition, differ-
ences in the design of the surveillance programmes or in
the structure of the sheep populations, especially with
respect to age and genetic, could hide actual differences in
the estimates of the prevalence of AS and since data was
absent this could not be assessed.
Conclusion
The Neuroprion task group on epidemiology of AS col-
lected data on active surveillance of TSEs in sheep between
2002 and 2006 from 20 European countries. This has pro-
vided the first opportunity to compare the epidemiologi-
cal situation of CS and AS simultaneously in different
countries. This descriptive study has shown that the prev-
alence estimates of CS and AS have different patterns; the
prevalence of CS has more variation than that of AS,
which is remarkably homogenous. Since some biases and
differences between countries were reported but not
quantitatively assessed, it might be argued that the
observed differences in the patterns of the prevalence of
AS and CS are due, at least in part, to such biases. How-
ever, it would be unlikely that biases in different countries
would consistently reduce the variability of ASPEs and not
those of CSPEs. If complementary data becomes available,
further analysis could explore some of the differences
between countries, e.g. through adaptation of meta-anal-
ysis [49].
Methods
Data collection
In July 2006, a questionnaire was submitted to represent-
atives of 27 European countries (Austria, Belgium, Bul-
garia, Cyprus, Czech Republic, Denmark, Estonia,
Finland, France, Germany, Greece, Hungary, Ireland,
Italy, Latvia, Lithuania, Luxembourg, Malta, The Nether-
lands, Poland, Portugal, Romania, Slovakia, Slovenia,
Spain, Sweden, United Kingdom) that were involved in
scrapie surveillance in accordance with EC regulation
999/2001 [48] with amendments and Iceland, Norway
and Switzerland. In each country, the questionnaire was
sent to both the Chief Veterinary Officer and the contacts
of the country in the EU Network of Excellence Neurop-
rion and former SRTSE Network. They were requested toBMC Veterinary Research 2008, 4:19 http://www.biomedcentral.com/1746-6148/4/19
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co-ordinate the completion and return of the question-
naire. A reminder was sent to countries in September and
by the end of 2006 a preliminary description of contribu-
tions was returned to each participant, in order to check
and to complete answers. Data collection was closed in
May 2007.
The questionnaire covered information on both the
design of the surveillance programmes for TSE in each of
the healthy slaughter and fallen stock populations of
sheep and the results for each year. For each surveillance
stream (healthy slaughter or fallen stock), details of the
sampling rate, the age structure of the sampled popula-
tion, the identified or potential biases and any changes
made in the surveillance programmes were requested. The
number of sheep tested, the number of sheep with posi-
tive test results for AS and CS, and the make and type of
TSE screening tests used were requested for each year of
active surveillance from 2001 to 2006. Data on the age
and genotype of atypical and CS cases (detected by active
surveillance or TSE eradication programmes) were sought
as well as data about PrP genotype frequencies from any
sampled population within each country. Each country
was asked for information about when it had the capacity
to diagnose AS. A copy of the questionnaire is available
from the corresponding author.
Data analysis
The questionnaire data were entered in a MS Access data-
base (Microsoft® Access 2000 version 9.0. Microsoft cor-
poration, WA, USA), statistical analysis and graphics were
performed with R 2.4.0 [68], and maps were created with
MapInfo (MapInfo Professional Version 5.5. 1985–1999
MapInfo corporation, NY, USA). For all statistical tests
performed the significance level was set to 0.05.
Classical scrapie prevalence estimates
A 'positive classical' test result was a sample that was
tested with any TSE screening test, gave a positive result
and was confirmed as meeting the diagnostic criteria for
CS [28]. In Cyprus, where discriminatory testing between
CS and AS in active surveillance was not performed rou-
tinely the positive cases are expressed as TSE positive
cases. A 'negative classical' test result was a sample tested
with any screening test, that either gave a negative result or
gave a positive result and thereafter confirmed as meeting
the definition of AS [28]. The CSPE was calculated as the
number of positive classical test results divided by the
total number of screening test results, for each country,
year and surveillance stream. The CSPEs were expressed as
percentages.
Atypical scrapie prevalence estimates
The sensitivity for AS of some of the screening tests used
in ovine TSE surveillance has been documented to be low
[28] and we chose to include only the tests recommended
for screening for AS when using brainstem material only,
namely test A, F and G. A 'positive atypical' test result was
a sample that was tested with either test A, F or G, gave a
positive result and was then confirmed as meeting the def-
inition of AS [28]. A 'negative atypical' result was a sample
that was tested with either test A, F or G, and that either
gave a negative result or that gave a positive result which
was not confirmed as meeting the definition of AS [28].
The ASPE was defined as the number of positive atypical
results divided by the sum of the positive and negative
atypical test results and was expressed as a percentage.
ASPE was calculated for each country, year, and surveil-
lance stream from the time the country was reported to
have the capacity to diagnose AS. For each country and
surveillance stream, analysis of the detection of AS started
from the period the country was considered able to diag-
nose an AS case. Diagnosis of AS was taken to consist of
having both the ability to detect (use of appropriate
screening test) and the ability to confirm AS (access to
appropriate confirmatory diagnostic tests). That period
was set as the first complete year after the date on which
the country reported that it had the capacity to diagnose
AS, and any of the tests A, F or G was used. If the time from
when the country reported that it had the capacity to diag-
nose AS coincided with the introduction of any of the tests
A, F or G, the corresponding year was included since all
the tests A, F or G performed during that year could have
led to the detection of AS [see Additional file 2]. The ASPE
was not estimated for 2003 in Northern Ireland because
the test A and C were reported together.
Confidence intervals
Exact binomial 95% confidence intervals (CI) were com-
puted for each prevalence estimate [see Additional file 1].
The occurrence of each type of scrapie within a country
Logistic regression was used in order to investigate
whether, within a country, the prevalence estimates varied
between the two surveillance streams and/or over time.
This was evaluated separately for each country and
scrapie-type.
The outcome variable was the logit transform of the
number of positive test results divided by the total
number of negative and positive test results, as defined
above in the estimates of prevalence for each scrapie-type.
The explanatory variables were the surveillance stream
(healthy slaughter or fallen stock, with healthy slaughter
as the stream of reference) and year of surveillance. The
year of reference of surveillance was the first year of sur-
veillance applicable to the given country for the scrapie-
type under investigation. The effect of the inclusion ofBMC Veterinary Research 2008, 4:19 http://www.biomedcentral.com/1746-6148/4/19
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each explanatory variable was tested by log-likelihood
ratio test.
If the year of surveillance was found as a categorical varia-
ble, then both a linear effect over time and an interaction
with the surveillance stream were tested for. Differences in
prevalence estimates by year of surveillance were also
tested for using the Chi-square test for linear trend.
If one of the two surveillance streams had only zero val-
ues, the effect of the year of surveillance was tested by
using exact logistic regression. In the absence of a signifi-
cant effect of the year of surveillance, all years were pooled
and the Fisher exact test was performed to test for differ-
ences in the prevalence estimates of the two surveillance
streams.
Comparison of the prevalence of the two different types of 
scrapie within a surveillance stream and within a country
The comparison of the prevalence of the two types of
scrapie was performed, within a surveillance stream, by
using the Mantel Haenszel test adjusted on year, or the
Pearson Chi-square test if data from only one year of sur-
veillance were available.
Probability to detect at least one case of AS
For each country that was capable of detecting AS, but
which did not detect any AS case, the probability of detect-
ing at least one AS case among all tested animals was esti-
mated for the situation where the within country ASPE
was set to equal the calculated overall prevalence of atyp-
ical scrapie in the responding countries. Assuming that the
detection of an AS case is a Bernoulli variable that follows
a binomial distribution (cases are assumed to be inde-
pendent), the probability to detect no case of AS among n
tests is:
Where p is the prevalence of AS and Se the diagnostic sen-
sitivity of the surveillance programme.
Comparison of the age of the cases
In the absence of individual animal records, the age of
sheep can be estimated by examination of dentition,
which is an imprecise science [69]. Because we had mixed
methods of ageing, we had to set broad age categories,
compatible with the less accurate data from dentition. Age
of cases were categorised into five broad classes (less than
18 months, 18 to 36 months, 36 to 60 months, 60 to 96
months and over 96 months). When age was given as a
minimum (> xx months), the age was set to the class cor-
responding to that minimum. Differences in the age dis-
tribution of atypical and CS cases, within each
surveillance stream (healthy slaughter, fallen stock and
animals culled in TSE eradication activities), were tested
using the Mann-Whitney test.
Description of the genotype of the cases
The PrP genotype of cases requested was limited to infor-
mation on the codons 136, 154 and 171, because codon
141 determination was not yet a routine procedure
throughout the EU. Data on cases detected through TSE
eradication activities (for example, the culling of affected
flocks) were excluded from the analysis because of poten-
tial selection biases, since most eradication programmes
select animals for testing preferentially according to their
genotype. For each type of scrapie, the frequencies of
allele carriers were calculated as the number of cases car-
rying the allele (homozygous or heterozygous) over the
number of cases. The distribution of the allele carrier fre-
quencies found in CS and in AS cases in each surveillance
stream was compared by a Chi-square test.
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